Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

NCT00399438 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea

NCT05719896 ·Status: UNKNOWN ·Phase: PHASE2

Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

NCT02316899 ·Status: COMPLETED ·Phase: PHASE3

A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome

NCT00918411 ·Status: COMPLETED ·Phase: PHASE4

Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

NCT00699166 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

NCT00394173 ·Status: COMPLETED ·Phase: PHASE2

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT02107196 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

NCT01896583 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

NCT01844180 ·Status: COMPLETED ·Phase: PHASE2

Diarrhea Predominant Irritable Bowel Syndrome in Females

NCT00461526 ·Status: COMPLETED ·Phase: PHASE2

Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment

NCT01893606 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)

NCT01303224 ·Status: COMPLETED ·Phase: PHASE2

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

NCT01100684 ·Status: COMPLETED ·Phase: PHASE3

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

NCT06153420 ·Status: TERMINATED ·Phase: PHASE2

Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome

NCT00385099 ·Status: COMPLETED ·Phase: PHASE2

A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients

NCT05900752 ·Status: COMPLETED ·Phase: NA

Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

NCT00067561 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)

NCT01340053 ·Status: COMPLETED ·Phase: PHASE2

12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT02320318 ·Status: WITHDRAWN ·Phase: PHASE3

Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.

NCT01854060 ·Status: COMPLETED

Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

NCT00179582 ·Status: TERMINATED ·Phase: NA

Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)

NCT00761007 ·Status: COMPLETED ·Phase: PHASE2

The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients

NCT05972317 ·Status: RECRUITING ·Phase: NA

52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)

NCT02120027 ·Status: TERMINATED ·Phase: PHASE3

A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)

NCT00394186 ·Status: COMPLETED ·Phase: PHASE2